| Background: | The protein encoded by this gene has a C-terminal domain with tRNA 3′ processing endoribonuclease activity, which catalyzes the removal of the 3' trailer from precursor tRNAs. The protein also interacts with activated Smad family member 2 (Smad2) and its nuclear partner forkhead box H1 (also known as FAST-1), and reduced expression can suppress transforming growth factor-beta induced growth arrest. Mutations in this gene result in an increased risk of prostate cancer. Multiple transcript variants encoding different isoforms have been found for this gene. | 
| Applications: | ELISA, WB, IHC | 
| Name of antibody: | ELAC2 | 
| Immunogen: | Fusion protein of human ELAC2 | 
| Full name: | elaC ribonuclease Z 2 | 
| Synonyms: | ELC2; HPC2; COXPD17 | 
| SwissProt: | Q9BQ52 | 
| IHC positive control: | Human gastric cancer and human liver cancer | 
| IHC Recommend dilution: | 50-200 | 
| WB Predicted band size: | 92 kDa | 
| WB Positive control: | LoVo and Hela cells | 
| WB Recommended dilution: | 200-1000 | 
	
	
 
 购物车
购物车 帮助
帮助
 021-54845833/15800441009
021-54845833/15800441009 
              